|
|
41
|
29958
|
SYNTHROID 75MCG TAB (ABB) THYROXINE
|
30'S
|
A
|
0.2582
|
75MCG
|
90
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
29958
|
SYNTHROID 75MCG TAB (ABB) LEVOTHYROXINE
|
30'S
|
A
|
0.23
|
75MCG
|
90
|
2026-04-01
|
2028-03-31
|
No
|
No
|
|
6
|
|
|
42
|
2995B
|
EUTIROX NF 75MCG TAB (MEK) LEVOTHYROXINE
|
50'S
|
A
|
0.37
|
75MCG
|
90
|
2026-04-01
|
2028-03-31
|
No
|
No
|
|
6
|
|
|
41
|
29961
|
EUTIROX 125MCG TAB (MEK) THYROXINE
|
50'S
|
A
|
0.4121
|
125MCG
|
30
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
29963
|
SYNTHROID 125MCG TAB (ABB) LEVOTHYROXINE
|
30'S
|
A
|
0.26
|
125MCG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
29964
|
EUTIROX NF 125MCG TAB (MEK) LEVOTHYROXINE
|
50'S
|
A
|
0.42
|
125MCG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
29973
|
SYNTHROID 150MCG TAB (ABB) LEVOTHYROXINE
|
30'S
|
A
|
0.27
|
150MCG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
29974
|
EUTIROX NF 150MCG TAB (MEK) LEVOTHYROXINE
|
50'S
|
A
|
0.42
|
150MCG
|
30
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
30016
|
BUPIVACAINE 0.25% INJ (KWA/ATB)
|
10ML
|
BQ
|
6.12
|
0.25%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
30016
|
BUPIVACAINE 0.25% INJ (KWA)
|
10ML
|
BQ
|
5.3551
|
0.25%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
3002X
|
LABUPI 0.25% INJ (LDP/AHI) BUPIVACAINE
|
20ML
|
BQ
|
15.22
|
0.25%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
3002Y
|
BUPIVACAINE 0.25% INJ (KWA/ATB)
|
20ML
|
BQ
|
8.56
|
0.25%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
Add to Contract as Cat B
|
0
|
|
|
41
|
3002Y
|
BUPIVACAINE 0.25% INJ (KWA)
|
20ML
|
BQ
|
15.9566
|
0.25%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
3002Z
|
BUPIVACAINE 0.25% INJ (BAX)
|
5X20ML
|
BQ
|
3.54
|
0.25%
|
2
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
42
|
30034
|
BUPIVACAINE SPINAL HEAVY 0.5% INJ (RTM)
|
10X4ML
|
BQ
|
2.83
|
0.5%
|
2
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
3003G
|
BUPIVACINE SPINAL HEAVY 0.5% INJ (BAX/STO) BU
|
5X4ML
|
BQ
|
4.02
|
0.5%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3003L
|
BUPIVACAINE HEAVY 0.5% INJ (FSB) (BQ)
|
5X4ML
|
BQ
|
1.9681
|
0.5%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
3003N
|
BUPIVACAINE HEAVY 0.5% INJ (FSB)
|
5X4ML
|
BQ
|
1.84
|
0.5%
|
2
|
2026-04-01
|
|
No
|
No
|
Add to Contract
|
0
|
|
|
40
|
3004F
|
LABUPI 0.5% INJ (LDP/AHI) BUPIVACAINE
|
10ML
|
BQ
|
6.36
|
0.5%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3004H
|
BUPIVACAINE 0.5% INJ (FSB)
|
20ML
|
BQ
|
7.5298
|
0.5%
|
2
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|